Warning letter woes: Dr Reddy's expects FDA inspection of AP plant by year-end

USFDA had issued warning letter in November 2015 relating to Current
Good Manufacturing Practice deviations at DR Reddy's API manufacturing
facilities at Srikakulam.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/warning-letter-woes-dr-reddys-expects-fda-inspection-of-ap-plant-by-year-end/articleshow/70447944.cms

Comments

Popular posts from this blog

Clinical Database Management Professional Vacancy @ Teva

Pharma Production Executive Post Vacancy @ Intas

Biotecnika Times – Newsletter 28.02.2020 – DST Women Scientist WOS B, DBT-IOC Recruitment